As a comment to the subtitle ”The challenge”, one can easily state that the entire 2020 has been a challenge and that probably none of us ever will remember the year of the worldwide corona pandemic as an uncomplicated year.
But here we are in 2018-2019 and still oblivious to what is about to hit the world. AstraZeneca’s R & D centre, that previously moved from Lund in the south of Sweden to Gothenburg, built in 2018 extra storeys specifically dedicated to research. The company envisioned two 3D-rooms where researchers could understand molecules by interacting with molecular models in 3D.
NANCO, who already in early 2000 had installed a 3D-projector and 3D-glasses in Lund and subsequently moved the setup to Gothenburg, was entrusted to install both rooms. With hindsight and the oncoming circumstances of endangered world health in mind, the more opportune the installation at this biomedical company, where vital research and clinical testing lead to the development of much needed medicine, seems to be.
Both 3D-rooms were quite straightforward to install:
The second and smaller room, was planned to be installed in March 2020, just as the corona pandemic went worldwide putting everything on hold. By June 2020, it was decided that the installation would be implemented under strict corona restrictions and following AstraZeneca’s thorough safety requirements.
This installation was similar to the previous one. NANCO built the smaller screen (2.7m*1.6m) onto its frame (2.9m*1.8m) in a proportionally larger room and then installed it into place together with one projector remote-controlled by a POE control system – and 3D-glasses. This smaller setup allows only one projection source at a time, displaying either the AstraZeneca workstation or a laptop presentation.
Two 3D-rooms, one large for parallell projection of 3D-molecular models and presentations and one smaller room alternately displaying one of these sources.